CG
MRVI icon

Caprock Group’s Maravai LifeSciences MRVI Stock Holding History

Caprock Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,338
Closed -$129K – 679
2023
Q2 		$129K Sell
10,338
-268
-3% -$3.62K 0.01% 635
2023
Q1 		$149K Sell
10,606
-545
-5% -$7.83K 0.01% 611
2022
Q4 		$160K Sell
11,151
-288
-3% -$4.54K 0.01% 518
2022
Q3 		$292K Buy
11,439
+1,488
+15% +$37.3K 0.03% 411
2022
Q2 		$283K Buy
9,951
+218
+2% +$6.91K 0.03% 394
2022
Q1 		$343K Buy
9,733
+726
+8% +$24.3K 0.03% 374
2021
Q4 		$377K Buy
+9,007
New +$365K 0.03% 353

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Caprock Group's MRVI Position: Q3 2023 in Review

Caprock Group sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 10,338 shares — an estimated $129K sold.

Caprock Group first reported a position in MRVI in Q4 2021 and held it in 7 quarters. The position peaked at $377K in Q4 2021. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

  • Caprock Group reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Caprock Group sold 10,338 Maravai LifeSciences shares in Q3 2023, an estimated $129K.
  • Caprock Group first reported a position in Maravai LifeSciences in Q4 2021 and held it in 7 quarters.
  • Caprock Group's Maravai LifeSciences position peaked at $377K in Q4 2021.
  • 204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on Caprock Group's 13F filing for Q3 2023, filed 18 Oct 2023.